ComplexID	ComplexName	Organism	Synonyms	Cell.line	subunits.UniProt.IDs.	subunits.Entrez.IDs.	Protein.complex.purification.method	GO.ID	GO.description	FunCat.ID	FunCat.description	PubMed.ID	subunits.Protein.name.	subunits.Gene.name.	subunits.Gene.name.syn.	Disease.comment	Subunits.comment	Complex.comment	SWISSPROT.organism	Num.Uniprot.IDs	MyListOverlap	querysize	expected	FCEnrichment	pvalue	Comparisons
1	BCL6-HDAC4 complex	Human	None	None	P41182;P56524	604;9759	MI:0007- anti tag coimmunoprecipitation	GO:0006265;GO:0045892;GO:0006473;GO:0006476;GO:0051276;GO:0030183;GO:0005634	DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;B cell differentiation;nucleus	10.01.09.05;11.02.03.04.03;14.07.04;42.10.03;43.03.07.02.01.01;70.10	DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;B-cell;nucleus	11929873	B-cell lymphoma 6 protein ;Histone deacetylase 4	BCL6;HDAC4	BCL5 LAZ3 ZBTB27 ZNF51;KIAA0288	None	None	Transcriptional repression by BCL6 is thought to be achieved in part by recruiting a repressor complex containing histone deacetylases.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
3	BCL6-HDAC7 complex	Human	None	None	P41182;Q8WUI4	604;51564	MI:0007- anti tag coimmunoprecipitation	GO:0006265;GO:0045892;GO:0006473;GO:0006476;GO:0051276;GO:0030183;GO:0005634	DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;B cell differentiation;nucleus	10.01.09.05;11.02.03.04.03;14.07.04;42.10.03;43.03.07.02.01.01;70.10	DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;B-cell;nucleus	11929873	B-cell lymphoma 6 protein ;Histone deacetylase 7	BCL6;HDAC7	BCL5 LAZ3 ZBTB27 ZNF51;HDAC7A	None	None	Transcriptional repression by BCL6 is thought to be achieved in part by recruiting a repressor complex containing histone deacetylases.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
55	HDAC4-ERK1 complex	Human	None	None	P27361;P56524	5595;9759	MI:0007- anti tag coimmunoprecipitation	GO:0006265;GO:2001141;GO:0006355;GO:0000165;GO:0051276;GO:0005634	DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;MAPK cascade;chromosome organization;nucleus	10.01.09.05;11.02.03.04;30.01.05.01.03;42.10.03;70.10	DNA conformation modification (e.g. chromatin);transcriptional control;MAPKKK cascade;organization of chromosome structure;nucleus	11114188	Mitogen-activated protein kinase 3;Histone deacetylase 4	MAPK3;HDAC4	ERK1, PRKM3;KIAA0288	None	None	ERK1 activity links the Ras-MAPK signal transduction pathway to a mechanism for chromatin remodeling (i.e., histone deacetylation).	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
57	HDAC4-ERK2 complex	Human	None	None	P28482;P56524	5594;9759	MI:0007- anti tag coimmunoprecipitation	GO:0006265;GO:2001141;GO:0006355;GO:0000165;GO:0051276;GO:0005634	DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;MAPK cascade;chromosome organization;nucleus	10.01.09.05;11.02.03.04;30.01.05.01.03;42.10.03;70.10	DNA conformation modification (e.g. chromatin);transcriptional control;MAPKKK cascade;organization of chromosome structure;nucleus	11114188	Mitogen-activated protein kinase 1;Histone deacetylase 4	MAPK1;HDAC4	ERK2, PRKM1, PRKM2;KIAA0288	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
72	R/M complex (RAD50-MRE11 complex)	Human	None	None	P49959;Q92878	4361;10111	MI:0071- molecular sieving	GO:0006308;GO:0006281;GO:0003677;GO:0006974;GO:0051276;GO:0005634	DNA catabolic process;DNA repair;DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	01.03.16.03;10.01.05.01;16.03.01;32.01.09;42.10.03;70.10	DNA degradation;DNA repair;DNA binding;DNA damage response;organization of chromosome structure;nucleus	9651580	Double-strand break repair protein MRE11A ;DNA repair protein RAD50	MRE11A;RAD50	HNGS1 MRE11;	None	None	Mre11 by itself has 3' to 5' exonuclease activity that is increased when Mre11 is in a complex with Rad50.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
236	WICH complex	Human	WSTF-ISWI chromatin remodeling complex	None	O60264;Q9UIG0	8467;9031	MI:0096- pull down	GO:0006265;GO:0005515;GO:0003677;GO:0005524;GO:0005694	DNA topological change;protein binding;DNA binding;ATP binding;chromosome	10.01.09.05;16.01;16.03.01;16.19.03;70.10.03	DNA conformation modification (e.g. chromatin);protein binding;DNA binding;ATP binding;chromosome	11980720	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5;Tyrosine-protein kinase BAZ1B	SMARCA5;BAZ1B	SNF2H WCRF135;WBSC10 WBSCR10 WBSCR9 WSTF	None	None	WICH is a member of the ISWI-containing chromatin remodelling complexes.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
263	R/M complex (RAD50-MRE11 complex)	Human	None	None	P49959;Q92878	4361;10111	MI:0004- affinity chromatography technologies; MI:0428- imaging techniques	GO:0006308;GO:0006281;GO:0003677;GO:0006974;GO:0051276;GO:0005634	DNA catabolic process;DNA repair;DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	01.03.16.03;10.01.05.01;16.03.01;32.01.09;42.10.03;70.10	DNA degradation;DNA repair;DNA binding;DNA damage response;organization of chromosome structure;nucleus	11741547	Double-strand break repair protein MRE11A ;DNA repair protein RAD50	MRE11A;RAD50	HNGS1 MRE11;	None	None	R/M consists of two highly flexible intramolecular coiled coils emanating from a central globular DNA binding domain.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
264	R/M complex (RAD50-MRE11 complex)	Human	None	None	P49959;Q92878	4361;10111	MI:0428- imaging techniques	GO:0006308;GO:0006281;GO:0003677;GO:0006974;GO:0051276;GO:0005634	DNA catabolic process;DNA repair;DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	01.03.16.03;10.01.05.01;16.03.01;32.01.09;42.10.03;70.10	DNA degradation;DNA repair;DNA binding;DNA damage response;organization of chromosome structure;nucleus	15165861	Double-strand break repair protein MRE11A ;DNA repair protein RAD50	MRE11A;RAD50	HNGS1 MRE11;	None	None	Human Rad50-Mre11 complexes are predominantly heterotetramers.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
265	ATR-ATRIP complex	Human	None	None	Q13535;Q8WXE1	545;84126	MI:0091- chromatography technologies; MI:0071- molecular sieving	GO:0000075;GO:0003677;GO:0006974;GO:0005634	cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	10.03.01.03;16.03.01;32.01.09;70.10	cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus	14724280	Serine/threonine-protein kinase ATR ;ATR-interacting protein	ATR;ATRIP	FRP1;AGS1	None	None	ATR and ATRIP associate with chromatin in vivo, and they exist as a large molecular weight complex that can bind single-stranded (ss)DNA cellulose in vitro. Neither ATR nor ATRIP are able to bind DNA individually, nor do they bind DNA in a cooperative manner.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
408	Guanylyl cyclase, soluble (GUCY1A3, GUCY1B3)	Human	None	None	Q02108;Q02153	2982;2983	MI:0028- cosedimentation in solution	GO:0009187;GO:0005515;GO:0005737	cyclic nucleotide metabolic process;protein binding;cytoplasm	01.03.10;16.01;70.03	metabolism of cyclic and unusual nucleotides;protein binding;cytoplasm	1683630	Guanylate cyclase soluble subunit alpha-3 ;Guanylate cyclase soluble subunit beta-1	GUCY1A3;GUCY1B3	GUC1A3 GUCSA3 GUCY1A1;GUC1B3 GUCSB3 GUCY1B1	None	None	Two soluble guanylyl cyclase complexes were found in mammals.  The GUCY1A3-GUCY1B3 complex exhibits higher guanylyl cyclase activity than the GUCY1A2-GUCY1B3 complex.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
559	Decapping complex	Human	None	None	P26196;Q6P2E9;Q8IU60;Q96F86;Q9NPI6	1656;23644;167227;80153;55802	MI:0019- coimmunoprecipitation	GO:0043488;GO:0005737	regulation of mRNA stability;cytoplasm	11.04.03.11;70.03	control of mRNA stability;cytoplasm	16364915	Probable ATP-dependent RNA helicase DDX6;Enhancer of mRNA-decapping protein 4 ;m7GpppN-mRNA hydrolase ;Enhancer of mRNA-decapping protein 3 ;mRNA-decapping enzyme 1A	DDX6;EDC4;DCP2;EDC3;DCP1A	HLR2 RCK;HEDLS;NUDT20;LSM16 YJDC YJEFN2;SMIF	None	None	Decapping is a key step in mRNA turnover. The decapping complex was found to be localized in cytoplasmic processing bodies (PBs), which are thought to be the sites of mRNA decay.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	5	2	537	0.761486103233125	2.62644320297952	0.0276477052120647	Cal33-HSC6
775	CBC complex (cap binding complex)	Human	None	None	P52298;Q09161	22916;4686	MI:0114- x-ray crystallography	GO:0003723;GO:0050658;GO:0051033;GO:0051169;GO:0005634	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	16.03.03;20.01.21;20.09.01;70.10	RNA binding;RNA transport;nuclear transport;nucleus	11545740	Nuclear cap-binding protein subunit 2;Nuclear cap-binding protein subunit 1	NCBP2;NCBP1	CBP20;CBP80 NCBP	None	None	The heterodimeric nuclear cap binding complex (CBC) binds to 5'-capped polymerase II transcripts. It enhances the efficiency of several mRNA maturation steps and is essential for U snRNA nuclear export in multicellular eukaryotes.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
783	ITCH-FAM/USP9x complex	Human	None	None	Q93008;Q96J02	8239;83737	MI:0004- affinity chromatography technologies; MI:0019- coimmunoprecipitation; MI:0069- mass spectrometry studies of complexes	GO:0016567;GO:0016579;GO:0005515;GO:0050789	protein ubiquitination;protein deubiquitination;protein binding;regulation of biological process	14.07.05;16.01;18	modification by ubiquitination, deubiquitination;protein binding;REGULATION OF METABOLISM AND PROTEIN FUNCTION	17038327	Probable ubiquitin carboxyl-terminal hydrolase FAF-X ;E3 ubiquitin-protein ligase Itchy homolog	USP9X;ITCH	DFFRX FAM USP9;	None	None	Interaction between Itch and FAM reverses Itch auto-ubiquitylation and protects the ligase from proteasomal degradation.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
847	RICH1-PAR3-aPKC polarity complex	Human	None	epithelium	P41743;Q68EM7;Q8TEW0	5584;55114;56288	MI:0007- anti tag coimmunoprecipitation	GO:0008104;GO:0005096;GO:0043547;GO:0007186;GO:0051211;GO:0007043;GO:0030054	protein localization;GTPase activator activity;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;anisotropic cell growth;cell-cell junction assembly;cell junction	18.01.03;18.02.01.01.01;30.05.02.24;40.01.03;42.06.04;70.06	regulation by localization;GTPase activator (GAP);G-protein coupled receptor signalling pathway;directional cell growth (morphogenesis);intercellular junction (gap junction/adherens junction);cell junction	16678097	Protein kinase C iota type;Rho GTPase-activating protein 17;Partitioning defective 3 homolog	PRKCI;ARHGAP17;PARD3	DXS1179E;RICH1;PAR3, PAR3A	None	None	Immunoblotting revealed aPKC and the 100 kDa isoform of Par-3, but not Par-6, in Rich1 immunoprecipitates. Par-3 and aPKC likely associate with Rich1 at lower levels than Pals1 and Patj since they were not identified by MS (see complex 846).	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
1045	Snurportin-CRM1-RanGTP complex	Human	None	None	O14980;O95149;P62826	7514;10073;5901	MI:0096- pull down	GO:0015031;GO:0008565;GO:0050658;GO:0051033;GO:0051169;GO:0005737;GO:0005634	protein transport;protein transporter activity;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	20.01.10;20.01.21;20.09.01;70.03;70.10	protein transport;RNA transport;nuclear transport;cytoplasm;nucleus	10209022	Exportin-1 ;Snurportin-1 ;GTP-binding nuclear protein Ran	XPO1;SNUPN;RAN	CRM1;RNUT1 SPN1;ARA24	None	None	The complex is exported from the nucleus to the cytoplasm where  RanGTP is removed from CRM1 through the action of RanBP1 and RanGAP.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	3	537	0.456891661939875	6.56610800744879	0	Cal33-HSC6
1079	P-TEFb.1 complex	Human	transcription elongation factor b.1 complex	None	O60563;P50750	904;1025	MI:0007- anti tag coimmunoprecipitation	GO:0006794;GO:0006796;GO:0006354;GO:0045893;GO:0006464;GO:0043085;GO:0008047;GO:0005634	phosphorus utilization;phosphate-containing compound metabolic process;DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;cellular protein modification process;positive regulation of catalytic activity;enzyme activator activity;nucleus	01.04;11.02.03.01.04;11.02.03.04.01;14.07;18.02.01.01;70.10	phosphate metabolism;transcription elongation;transcription activation;protein modification;enzyme activator;nucleus	9499409	Cyclin-T1;Cyclin-dependent kinase 9	CCNT1;CDK9	None;CDC2L4, TAK	None	None	Cyclin T activates CDK9 in the P-TEFb complex. P-TEFb works as a protein kinase that phosphorylates the C-terminal domain of the RNAPII largest subunit.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1082	P-TEFb.1 complex	Human	transcription elongation factor b.1 complex	None	O60563;P50750	904;1025	MI:0018- two hybrid; MI:0071- molecular sieving	GO:0006794;GO:0006796;GO:0006354;GO:0045893;GO:0006464;GO:0043085;GO:0008047;GO:0005634	phosphorus utilization;phosphate-containing compound metabolic process;DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;cellular protein modification process;positive regulation of catalytic activity;enzyme activator activity;nucleus	01.04;11.02.03.01.04;11.02.03.04.01;14.07;18.02.01.01;70.10	phosphate metabolism;transcription elongation;transcription activation;protein modification;enzyme activator;nucleus	10574912	Cyclin-T1;Cyclin-dependent kinase 9	CCNT1;CDK9	None;CDC2L4, TAK	None	None	Cyclin T activates CDK9 in the P-TEFb complex. P-TEFb works as a protein kinase that phosphorylates the C-terminal domain of the RNAPII largest subunit.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1117	CRM1-Survivin mitotic complex	Human	None	None	O14980;O15392	7514;332	MI:0007- anti tag coimmunoprecipitation	GO:0000278;GO:0051169;GO:0000775	mitotic cell cycle;nuclear transport;chromosome, centromeric region	10.03.01.01;20.09.01;70.10.04	mitotic cell cycle;nuclear transport;centromere / kinetochore	17099693	Exportin-1 ;Baculoviral IAP repeat-containing protein 5	XPO1;BIRC5	CRM1;API4, IAP4	None	None	The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1133	ATR-HDAC2 complex	Human	None	None	Q13535;Q92769	545;3066	MI:0004- affinity chromatography technologies; MI:0019- coimmunoprecipitation	GO:0006265;GO:0006473;GO:0006476;GO:0051276	DNA topological change;protein acetylation;protein deacetylation;chromosome organization	10.01.09.05;14.07.04;42.10.03	DNA conformation modification (e.g. chromatin);modification by acetylation, deacetylation;organization of chromosome structure	10545197	Serine/threonine-protein kinase ATR ;Histone deacetylase 2	ATR;HDAC2	FRP1;None	None	None	The ATR-HDAC2 complex is a robust biochemical entity that withstands ammonium sulfate precipitation and anion exchange chromatography.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1172	CBC complex (cap binding complex)	Human	None	None	P52298;Q09161	22916;4686	MI:0413- electrophoretic mobility shift assay	GO:0003723;GO:0050658;GO:0051033;GO:0051169;GO:0005634	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	16.03.03;20.01.21;20.09.01;70.10	RNA binding;RNA transport;nuclear transport;nucleus	10786834	Nuclear cap-binding protein subunit 2;Nuclear cap-binding protein subunit 1	NCBP2;NCBP1	CBP20;CBP80 NCBP	None	None	The heterodimeric nuclear cap binding complex (CBC) binds to 5'-capped polymerase II transcripts. It enhances the efficiency of several mRNA maturation steps and is essential for U snRNA nuclear export in multicellular eukaryotes.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1176	CRM1-RAN-PHAX-CBC complex (cap binding complex)	Human	None	None	O14980;P52298;P62826;Q09161;Q9H814	7514;22916;5901;4686;51808	MI:0413- electrophoretic mobility shift assay; MI:0430- nucleic acid uv cross-linking assay	GO:0003723;GO:0050658;GO:0051033;GO:0051169;GO:0005737;GO:0005634	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	16.03.03;20.01.21;20.09.01;70.03;70.10	RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	10786834	Exportin-1 ;Nuclear cap-binding protein subunit 2;GTP-binding nuclear protein Ran;Nuclear cap-binding protein subunit 1;Phosphorylated adapter RNA export protein	XPO1;NCBP2;RAN;NCBP1;PHAX	CRM1;CBP20;ARA24;CBP80 NCBP;RNUXA	None	None	In metazoa, assembly of spliceosomal U snRNPs requires nuclear export of U snRNA precursors. Export depends upon the RNA cap structure, nuclear cap-binding complex (CBC), the export receptor CRM1/Xpo1, and RanGTP. PHAX (phosphorylated adaptor for RNA export) is an additional factor required for U snRNA export complex assembly in vitro. PHAX binding to CBC is greatly increased by the presence of capped RNA. Phosphorylated PHAX can bind to RanGTP/Xpo1 but does so more strongly in the presence of CBC and even more in the presence of both CBC and RNA. Thus, every step in U snRNA export complex formation involves some degree of cooperativity.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	5	3	537	0.761486103233125	3.93966480446927	0.00234190693642556	Cal33-HSC6
1190	NCBP-NIP1 complex	Human	None	None	Q09161;Q96P71	4686;63941	MI:0018- two hybrid	GO:0003723;GO:0050789;GO:0005634	RNA binding;regulation of biological process;nucleus	16.03.03;18;70.10	RNA binding;REGULATION OF METABOLISM AND PROTEIN FUNCTION;nucleus	7478990	Nuclear cap-binding protein subunit 1;N-terminal EF-hand calcium-binding protein 3	NCBP1;NECAB3	CBP80 NCBP;APBA2BP NIP1 SYTIP2 XB51	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1250	pRB-E2F-1 complex	Human	None	None	P06400;Q01094	5925;1869	MI:0019- coimmunoprecipitation	GO:0007050;GO:0006974;GO:0005634	cell cycle arrest;cellular response to DNA damage stimulus;nucleus	10.03.01.02;32.01.09;70.10	cell cycle arrest;DNA damage response;nucleus	17380128	Retinoblastoma-associated protein ;Transcription factor E2F1	RB1;E2F1	;RBBP3	None	None	The phosphorylation of pRB at Ser612 is induced by ATM-Chk1/2 kinase after DNA damage, leading to enhancement of the formation of a complex between pRB and E2F-1. It is proposed, that in asynchronously growing cells, pRB exists in a predominantly phosphorylated state, which is dissociated from E2F, allowing E2F-dependent transcription. DNA damage induces dephosphorylation of pRB at Cdk phosphorylation sites, leading to the complex pRB-E2F-1 being formed. DNA damage also activates ATM kinase and transduces signals to the checkpoint kinases Chk1 and Chk2. Activated Chk1 and Chk2 phosphorylate Ser612 of pRB and this phosphorylation enhances the formation of a complex between pRB and E2F-1, leading to repression of the transcriptional activity of E2F-1. Consequently, pRB-dependent cell cycle arrest and repression of apoptosis occur.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1296	DCP1A-DCP2 Decapping complex	Human	None	None	Q8IU60;Q9NPI6	167227;55802	MI:0019- coimmunoprecipitation	GO:0006401;GO:0005737	RNA catabolic process;cytoplasm	01.03.16.01;70.03	RNA degradation;cytoplasm	12417715	m7GpppN-mRNA hydrolase ;mRNA-decapping enzyme 1A	DCP2;DCP1A	NUDT20;SMIF	None	None	Although the authors suggest the existence of a protein complex containing DCP proteins and UPF proteins they also state that there is currently no direct evidence for the significance of a strong interaction between hUpf1 and hDcp proteins.	Homo sapiens (Human);Homo sapiens (Human)	2	2	537	0.30459444129325	6.56610800744879	0	Cal33-HSC6
1372	Rb-tal-1-E2A-Lmo2-Ldb1 complex	Human	None	None	P06400;P15923;P17542;P25791;Q86U70	5925;6929;6886;4005;8861	MI:0019- coimmunoprecipitation	GO:0045892;GO:0030218;GO:0005634	negative regulation of transcription, DNA-templated;erythrocyte differentiation;nucleus	11.02.03.04.03;43.03.07;70.10	transcription repression;blood cell;nucleus	10866689	Retinoblastoma-associated protein ;Transcription factor E2-alpha ;T-cell acute lymphocytic leukemia protein 1 ;Rhombotin-2 ;LIM domain-binding protein 1	RB1;TCF3;TAL1;LMO2;LDB1	;BHLHB21 E2A ITF1;BHLHA17 SCL TCL5;RBTN2 RBTNL1 RHOM2 TTG2;CLIM2	None	None	Data indicate that this pentameric complex assembled in maturing erythroblasts plays an important regulatory role in c-kit downmodulation; hypothetically, the complex may regulate the expression of other critical erythroid genes.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	5	2	537	0.761486103233125	2.62644320297952	0.0276477052120647	Cal33-HSC6
1380	Elongator holo complex	Human	None	None	O95163;Q6IA86;Q96EB1;Q9H9T3	8518;55250;26610;55140	MI:0029- cosedimentation through density gradients	GO:0006354;GO:0006473;GO:0006476;GO:0005634	DNA-templated transcription, elongation;protein acetylation;protein deacetylation;nucleus	11.02.03.01.04;14.07.04;70.10	transcription elongation;modification by acetylation, deacetylation;nucleus	11714725	Elongator complex protein 1 ;Elongator complex protein 2 ;Elongator complex protein 4 ;Elongator complex protein 3	IKBKAP;ELP2;ELP4;ELP3	ELP1 IKAP;STATIP1;C11orf19 PAXNEB;	None	Two other subunits of the complex were found in the analysis, which have not been further characterized: p38, p30.	The holo-Elongator complex has histone acetyltransferase activity directed against histone H3 and H4. Holo-Elongator interacts with RNA polymerase II.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	4	2	537	0.6091888825865	3.28305400372439	0.0124642262466812	Cal33-HSC6
1388	RB1-TFAP2A complex	Dog	None	None	P05549;Q9XSY1	7020;None	MI:0019- coimmunoprecipitation	GO:0045893	positive regulation of transcription, DNA-templated	11.02.03.04.01	transcription activation	9632747	Transcription factor AP-2-alpha ;Retinoblastoma protein	TFAP2A;RB1	AP2TF TFAP2;	None	Since TFAP2A from dog was not available in the UniProt database at the time of annotation, the orthologous protein from human was used.	None	Homo sapiens (Human);Canis lupus familiaris (Dog) (Canis familiaris)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1558	POLR1B-RRN3 complex	Human	None	None	Q9H9Y6;Q9NYV6	84172;54700	MI:0019- coimmunoprecipitation	GO:0009303	rRNA transcription	11.02.01	rRNA synthesis	15558034	DNA-directed RNA polymerase I subunit RPA2 ;RNA polymerase I-specific transcription initiation factor RRN3	POLR1B;RRN3	;TIFIA	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
1559	NMI-RRN3 complex	Human	None	None	Q13287;Q9NYV6	9111;54700	MI:0019- coimmunoprecipitation	GO:0009303	rRNA transcription	11.02.01	rRNA synthesis	15558034	N-myc-interactor ;RNA polymerase I-specific transcription initiation factor RRN3	NMI;RRN3	;TIFIA	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2171	Ubiquitin E3 ligase (CHEK1, CUL4A)	Human	None	None	O14757;Q13619	1111;8451	MI:0019- coimmunoprecipitation	GO:0016567;GO:0016579;GO:0043161;GO:0006511;GO:0006974;GO:0005634	protein ubiquitination;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;nucleus	14.07.05;14.13.01.01;32.01.09;70.10	modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);DNA damage response;nucleus	16137618	Serine/threonine-protein kinase Chk1 ;Cullin-4A	CHEK1;CUL4A	CHK1;None	None	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The Chk1 kinase is a major effector of S phase checkpoint signaling during the cellular response to genotoxic stress. Replicative stress induces the polyubiquitination and degradation of Chk1 in human cells.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2297	ABI1-WASL complex	Human	None	None	O00401;Q8IZP0	8976;10006	MI:0004- affinity chromatography technologies	GO:0030036	actin cytoskeleton organization	42.04.03	actin cytoskeleton	16155590	Neural Wiskott-Aldrich syndrome protein ;Abl interactor 1	WASL;ABI1	;SSH3BP1	Neural Wiskott-Aldrich syndrome	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2513	N-WASp homomer	Human	None	None	O00401	8976	MI:0031- protein cross-linking with a bifunctional reagent	GO:0030036	actin cytoskeleton organization	42.04.03	actin cytoskeleton	10781580	Neural Wiskott-Aldrich syndrome protein	WASL	None	None	None	N-WASp undergoes self-association upon increasing concentration and the monomeric form activates actin polymerization and is favored by Grb2 binding.	Homo sapiens (Human)	1	1	537	0.152297220646625	6.56610800744879	0	Cal33-HSC6
2655	MYC-MAX complex	Human	None	None	P01106;P61244	4609;4149	MI:0019- coimmunoprecipitation	GO:2001141;GO:0006355;GO:0003677	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding	11.02.03.04;16.03.01	transcriptional control;DNA binding	12584560	Myc proto-oncogene protein ;Protein max	MYC;MAX	BHLHE39;BHLHD4	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2678	FOXO3-TP53 complex, oxidative stress stimulated	Human	None	None	O43524;P04637	2309;7157	MI:0019- coimmunoprecipitation	GO:2001141;GO:0006355;GO:0000302;GO:0006979;GO:0005634	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress;nucleus	11.02.03.04;32.01.01;70.10	transcriptional control;oxidative stress response;nucleus	14976264	Forkhead box protein O3;Cellular tumor antigen p53	FOXO3;TP53	FKHRL1, FOXO3A;P53	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2679	p53-SP1 complex	Human	None	None	P04637;P08047	7157;6667	MI:0006- anti bait coimmunoprecipitation	GO:2001141;GO:0006355;GO:0003677;GO:0005634	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus	11.02.03.04;16.03.01;70.10	transcriptional control;DNA binding;nucleus	15674334	Cellular tumor antigen p53;Transcription factor Sp1	TP53;SP1	P53;TSFP1	None	None	The authors provide evidence that p53 repressed the RECQ4 promoter by forming a complex with the transcription factor, SP1, and by regulating promoter occupancy of both itself and SP1 in concert with histone deacetylase 1 (HDAC1). The formation of this complex is camptothecin-dependent.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2681	p53 homotetramer complex	Human	None	None	P04637	7157	MI:0031- protein cross-linking with a bifunctional reagent; MI:0276- blue native page	GO:2001141;GO:0006355;GO:0003677;GO:0005634	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus	11.02.03.04;16.03.01;70.10	transcriptional control;DNA binding;nucleus	15674341	Cellular tumor antigen p53	TP53	P53	None	None	The results demonstrate that Ref-1 (redox factor 1) modulates p53 DNA binding not only as a redox regulator but also as a factor, which facilitates the formation of p53 tetramers from higher oligomeric forms as well as from dimers. Ref-1 mediates de-stacking of higher oligomeric forms into individual tetramers, as well as the assembly of dimers into tetramers. Redox-dependent and redox-independent activation of p53 seem to require different amounts of Ref-1.	Homo sapiens (Human)	1	1	537	0.152297220646625	6.56610800744879	0	Cal33-HSC6
2699	ER-alpha-GRIP1-c-Jun complex	Human	None	None	P03372;P05412;Q9Y3R0	2099;3725;23426	MI:0096- pull down	GO:2001141;GO:0006355;GO:0023052	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signaling	11.02.03.04;30.01	transcriptional control;cellular signalling	11477071	Estrogen receptor;Transcription factor AP-1 ;Glutamate receptor-interacting protein 1	ESR1;JUN;GRIP1	ESR, NR3A1;;None	None	None	The authors showed that ERalpha , c-Jun, and the p160 coactivator GRIP1 can form a multiprotein complex in vitro and in intact cells and that the ERalpha - c-Jun interaction could be crucial for the stability of this complex.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
2700	ER-alpha-c-Jun complex	Human	None	None	P03372;P05412	2099;3725	MI:0096- pull down; MI:0019- coimmunoprecipitation	GO:2001141;GO:0006355;GO:0003677;GO:0023052	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;signaling	11.02.03.04;16.03.01;30.01	transcriptional control;DNA binding;cellular signalling	11477071	Estrogen receptor;Transcription factor AP-1	ESR1;JUN	ESR, NR3A1;	None	None	All experiments demonstrated that ER-alpha and c-Jun could interact in mammalian cells in a ligand-dependent manner.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2704	Ectodermin-SMAD4 complex	Human	None	None	Q13485;Q9UPN9	4089;51592	MI:0007- anti tag coimmunoprecipitation	GO:0016567;GO:0016579;GO:0007179;GO:0005634	protein ubiquitination;protein deubiquitination;transforming growth factor beta receptor signaling pathway;nucleus	14.07.05;30.05.01.18.01;70.10	modification by ubiquitination, deubiquitination;TGF-beta-receptor signalling pathway;nucleus	15820681	Mothers against decapentaplegic homolog 4;E3 ubiquitin-protein ligase TRIM33	SMAD4;TRIM33	DPC4 MADH4;KIAA1113 RFG7 TIF1G	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2714	Ubiquitin E3 ligase (CHEK1, CUL1)	Human	None	None	O14757;Q13616	1111;8454	MI:0019- coimmunoprecipitation	GO:0016567;GO:0016579;GO:0043161;GO:0006511;GO:0006974;GO:0005634	protein ubiquitination;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;nucleus	14.07.05;14.13.01.01;32.01.09;70.10	modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);DNA damage response;nucleus	16137618	Serine/threonine-protein kinase Chk1 ;Cullin-1	CHEK1;CUL1	CHK1;None	None	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The Chk1 kinase is a major effector of S phase checkpoint signaling during the cellular response to genotoxic stress. Replicative stress induces the polyubiquitination and degradation of Chk1 in human cells.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2776	RAD50-BRCA1 complex	Human	None	None	P38398;Q92878	672;10111	MI:0007- anti tag coimmunoprecipitation; MI:0226- ion exchange chromatography	GO:0006281;GO:0005634	DNA repair;nucleus	10.01.05.01;70.10	DNA repair;nucleus	11504724	Breast cancer type 1 susceptibility protein;DNA repair protein RAD50	BRCA1;RAD50	RNF53;	BRCA1 is involved in breast cancer.	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2815	BRCA1-BARD1-BACH1-DNA damage complex II	Human	None	None	O14867;O60934;P38398;P49959;Q92547;Q92878;Q99708;Q99728	571;4683;672;4361;11073;10111;5932;580	MI:0029- cosedimentation through density gradients; MI:0006- anti bait coimmunoprecipitation	GO:0006260;GO:0006281;GO:0000075;GO:0006974;GO:0005634	DNA replication;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	10.01.03;10.01.05.01;10.03.01.03;32.01.09;70.10	DNA synthesis and replication;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus	16391231	Transcription regulator protein BACH1 ;Nibrin ;Breast cancer type 1 susceptibility protein;Double-strand break repair protein MRE11A ;DNA topoisomerase 2-binding protein 1;DNA repair protein RAD50 ;DNA endonuclease RBBP8 ;BRCA1-associated RING domain protein 1	BACH1;NBN;BRCA1;MRE11A;TOPBP1;RAD50;RBBP8;BARD1	;NBS NBS1 P95;RNF53;HNGS1 MRE11;KIAA0259;;CTIP;	BRCA1 is involved in breast cancer.	None	This complex occurs after exposure to UV irradiation.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	8	3	537	1.218377765173	2.4622905027933	0.0223655979152085	Cal33-HSC6
2821	hSIR2-p53 complex	Human	None	None	P04637;Q96EB6	7157;23411	MI:0006- anti bait coimmunoprecipitation	GO:2001141;GO:0006355;GO:0006473;GO:0006476;GO:0006974;GO:0005634	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;cellular response to DNA damage stimulus;nucleus	11.02.03.04;14.07.04;32.01.09;70.10	transcriptional control;modification by acetylation, deacetylation;DNA damage response;nucleus	11672523	Cellular tumor antigen p53;NAD-dependent protein deacetylase sirtuin-1	TP53;SIRT1	P53;SIR2L1	None	None	The authors analyzed that hSir2 directly binds the human p53 protein in vivo and specifically deacetylates the K382 residue of p53.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2895	SHC-GRB2 complex	Human	None	None	P29353;P62993	6464;2885	MI:0006- anti bait coimmunoprecipitation	GO:0023052	signaling	30.01	cellular signalling	8112292	SHC-transforming protein 1;Growth factor receptor-bound protein 2	SHC1;GRB2	SHC SHCA;ASH	Chimeric bcr-abl oncogene is involved in Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL).	None	Bcr-Abl proteins induce the formation of a complex between tyrosine phosphorylated Shc and Grb2. Co-precipitation analysed in R1-p185, R1-p210 and in Ph(+) leucemic cell lines. No co-precipitation seen in parental R1 cells.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
2917	Grb2-Sos complex, Fc receptor gamma-R1 stimulated	Human	None	None	P62993;Q07889	2885;6654	MI:0019- coimmunoprecipitation	GO:0007169;GO:0006955	transmembrane receptor protein tyrosine kinase signaling pathway;immune response	30.05.01.12;36.25.16	transmembrane receptor protein tyrosine kinase signalling pathways;immune response	9716598	Growth factor receptor-bound protein 2;Son of sevenless homolog 1	GRB2;SOS1	ASH;None	None	None	In literature it has been shown that Grb2 binds to the guanine nucleotide exchange factor Sos, leading to activation of Ras.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
3052	MYC-MAX complex	Human	None	None	P01106;P61244	4609;4149	MI:0006- anti bait coimmunoprecipitation	GO:0045893;GO:0003677;GO:0005634	positive regulation of transcription, DNA-templated;DNA binding;nucleus	11.02.03.04.01;16.03.01;70.10	transcription activation;DNA binding;nucleus	8224841	Myc proto-oncogene protein ;Protein max	MYC;MAX	BHLHE39;BHLHD4	None	None	Cell differentiation is accompanied by a change from MYC-MAX complexes (undifferentiated cells) to MAD-MAX complexes (differentiated cells). The ability of MAD to compete with MYC for binding to MAX and to repress MYC transcriptional activation suggests that MAD opposes the function of MYC.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
3144	Sos1-Grb2 complex	Mammalia	None	COS cells	P62993;Q07889	2885;6654	MI:0096- pull down	GO:0007264;GO:0007169	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway	30.01.05.05.01;30.05.01.12	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways	11777939	Growth factor receptor-bound protein 2;Son of sevenless homolog 1	GRB2;SOS1	ASH;None	None	None	The authors describe the formation of either a Sos-1-Grb2 (S/G) or a Sos-1-E3b1-Eps8 (S/E/E8) complex, endowed with Ras- and Rac-specific GEF activities, respectively. Sos-1-Grb2 complex is disrupted upon RTKs (receptor tyrosine kinases) activation, whereas the S/E/E8 complex is not.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
3231	Eps15-stonin2 complex	Human	None	None	P42566;Q8WXE9	2060;85439	MI:0077- nuclear magnetic resonance	GO:0006886;GO:0006605;GO:0015031;GO:0016192	intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport	14.04;20.01.10;20.09.07	protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.)	18200045	Epidermal growth factor receptor substrate 15;Stonin-2	EPS15;STON2	AF1P;STN2 STNB	None	None	Eps15 and stonin2 have both been shown to directly associate with the clathrin adaptor complex AP-2 and to localize to clathrin-coated pits (CCPs).	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
3852	Rb-HDAC1 complex	Mammalia	None	CV-1 cells	P06400;Q13547	5925;3065	MI:0006- anti bait coimmunoprecipitation	GO:0006265;GO:0000082;GO:0045892;GO:0006473;GO:0006476;GO:0051276;GO:0005634	DNA topological change;G1/S transition of mitotic cell cycle;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;nucleus	10.01.09.05;10.03.01.01.03;11.02.03.04.03;14.07.04;42.10.03;70.10	DNA conformation modification (e.g. chromatin);G1/S transition of mitotic cell cycle;transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus	9491888	Retinoblastoma-associated protein ;Histone deacetylase 1	RB1;HDAC1	;RPD3L1	None	None	The interaction was analyzed in CV-1 cells expressing a mixture of endogenous and transfected proteins. H. sapiens is used as model organism for annotation of the subunits.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
3853	Rb-HDAC1 complex	Human	None	None	P06400;Q13547	5925;3065	MI:0007- anti tag coimmunoprecipitation	GO:0006265;GO:0000082;GO:0045892;GO:0006473;GO:0006476;GO:0051276;GO:0005634	DNA topological change;G1/S transition of mitotic cell cycle;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;nucleus	10.01.09.05;10.03.01.01.03;11.02.03.04.03;14.07.04;42.10.03;70.10	DNA conformation modification (e.g. chromatin);G1/S transition of mitotic cell cycle;transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus	9491888	Retinoblastoma-associated protein ;Histone deacetylase 1	RB1;HDAC1	;RPD3L1	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5099	RB1(hypophosphorylated)-E2F4 complex	Human	None	None	P06400;Q16254	5925;1874	MI:0006- anti bait coimmunoprecipitation	GO:0000082;GO:0045892	G1/S transition of mitotic cell cycle;negative regulation of transcription, DNA-templated	10.03.01.01.03;11.02.03.04.03	G1/S transition of mitotic cell cycle;transcription repression	9380698	Retinoblastoma-associated protein ;Transcription factor E2F4	RB1;E2F4	;	None	None	Hypo-phosphorylated Rb interacts with E2F4 in the early G1 phase of the cell cyclus. Inactivation of Rb by hyper-phosphorylation in late G1 phase causes release of E2F, allowing transcription of genes important for DNA synthesis.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5143	E2F1-Rb complex	Human	None	None	P06400;Q01094	5925;1869	MI:0412- electrophoretic mobility supershift assay; MI:0006- anti bait coimmunoprecipitation	GO:0000080;GO:2001141;GO:0006355	mitotic G1 phase;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated	10.03.01.01.01;11.02.03.04	G1 phase of mitotic cell cycle;transcriptional control	1531040	Retinoblastoma-associated protein ;Transcription factor E2F1	RB1;E2F1	;RBBP3	None	None	Rb forms a complex with E2F1 in the G1 phase of the cell cycle.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5146	RB1-TFAP2A complex	Human	None	None	P05549;P06400	7020;5925	MI:0019- coimmunoprecipitation	GO:0045893	positive regulation of transcription, DNA-templated	11.02.03.04.01	transcription activation	9632747	Transcription factor AP-2-alpha ;Retinoblastoma-associated protein	TFAP2A;RB1	AP2TF TFAP2;	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	2	537	0.30459444129325	6.56610800744879	0	Cal33-HSC6
5360	AGO2-FXR1-TNF(alpha)ARE-RNP complex	Human	None	None	P51114;Q9UKV8	8087;27161	MI:0030- cross-linking studies; MI:0004- affinity chromatography technologies; MI:0006- anti bait coimmunoprecipitation	GO:0006417;GO:0003723;GO:0005737	regulation of translation;RNA binding;cytoplasm	12.07;16.03.03;70.03	translational control;RNA binding;cytoplasm	17382880	Fragile X mental retardation syndrome-related protein 1 ;Protein argonaute-2	FXR1;AGO2	;EIF2C2	None	None	AGO2 functions as translational activator under serum-starved conditions.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5401	PLEKHM2-KIF5B complex	Human	SKIP-kinesin complex	HeLa cells	P33176;Q8IWE5	3799;23207	MI:0096- pull down	GO:0006928	movement of cell or subcellular component	34.05	cell motility	15905402	Kinesin-1 heavy chain;Pleckstrin homology domain-containing family M member 2	KIF5B;PLEKHM2	KNS, KNS1;KIAA0842 SKIP	None	None	During Salmonella typhimurium infection SKIP acts as an essential mediator of SifA (a S. thyphimurium protein, required for the formation of Salmonella-induced filaments). A dynamic process of kinesin recruitment in Salmonella-infected cells is mediated by the secretion of unidentified SPI-2 TTSS effectors and is down-regulated by the SifA-mediated recruitment of SKIP on membranes. The authors suggest that S. typhimurium is able to fine-tune the SCV-associated kinesin motor activity by regulating the secretion of its own effector proteins.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5441	NRG1-IKZF4 complex	Human	None	None	Q02297;Q9H2S9	3084;64375	MI:0019- coimmunoprecipitation	GO:2001141;GO:0006355	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated	11.02.03.04	transcriptional control	15494726	Pro-neuregulin-1, membrane-bound isoform ;Zinc finger protein Eos	NRG1;IKZF4	GGF HGL HRGA NDF SMDF;KIAA1782 ZNFN1A4	None	None	The Nrg-ICD-Eos complex induces endogenous PSD-95 expression in vivo through a signaling pathway that is mostly independent of gamma-secretase regulation. This upregulation of PSD-95 expression by the Nrg-ICD-Eos complex provides a molecular basis for activity-dependent synaptic plasticity.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5542	CCNB2-CDC2 complex	Human	None	None	O95067;P06493	9133;983	MI:0019- coimmunoprecipitation	GO:0007049	cell cycle	10.03	cell cycle	8070405	G2/mitotic-specific cyclin-B2;Cyclin-dependent kinase 1	CCNB2;CDK1	;CDC2 CDC28A CDKN1 P34CDC2	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5543	CCNB1-CDC2 complex	Human	None	None	P06493;P14635	983;891	MI:0019- coimmunoprecipitation	GO:0007049	cell cycle	10.03	cell cycle	8070405	Cyclin-dependent kinase 1 ;G2/mitotic-specific cyclin-B1	CDK1;CCNB1	CDC2 CDC28A CDKN1 P34CDC2;CCNB	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5557	CDC2-CCNA2 complex	Human	None	None	P06493;P20248	983;890	MI:0019- coimmunoprecipitation	GO:0007049	cell cycle	10.03	cell cycle	8423786	Cyclin-dependent kinase 1 ;Cyclin-A2	CDK1;CCNA2	CDC2 CDC28A CDKN1 P34CDC2;CCN1 CCNA	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5642	Securin-separase complex	Human	None	None	O95997;Q14674	9232;9700	MI:0027- cosedimentation; MI:0071- molecular sieving	GO:0000280;GO:0007059	nuclear division;chromosome segregation	10.03.04.07;10.03.04.05	nuclear division;chromosome segregation/division	15880121	Securin ;Separin	PTTG1;ESPL1	EAP1 PTTG TUTR1;ESP1 KIAA0165	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5643	ESPL1-CDC2 complex	Human	None	None	P06493;Q14674	983;9700	MI:0019- coimmunoprecipitation	GO:0000280;GO:0007059	nuclear division;chromosome segregation	10.03.04.07;10.03.04.05	nuclear division;chromosome segregation/division	15989971	Cyclin-dependent kinase 1 ;Separin	CDK1;ESPL1	CDC2 CDC28A CDKN1 P34CDC2;ESP1 KIAA0165	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	2	537	0.30459444129325	6.56610800744879	0	Cal33-HSC6
5648	FARP2-NRP1-PlexinA3 complex	Human	None	HEK 293 cells	O14786;O94887;P51805	8829;9855;55558	MI:0019- coimmunoprecipitation	GO:0023052;GO:0007399	signaling;nervous system development	30.01;47.03.01	cellular signalling;nervous system	16286926	Neuropilin-1;FERM, RhoGEF and pleckstrin domain-containing protein 2 ;Plexin-A3	NRP1;FARP2;PLXNA3	NRP VEGF165R;KIAA0793 PLEKHC3;PLXN4 SEX	None	None	None	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
5663	TRIM27-RB1 complex	Human	None	None	P06400;P14373	5925;5987	MI:0096- pull down; MI:0019- coimmunoprecipitation	GO:2001141;GO:0006355	regulation of RNA biosynthetic process;regulation of transcription, DNA-templated	11.02.03.04	transcriptional control	15837424	Retinoblastoma-associated protein ;Zinc finger protein RFP	RB1;TRIM27	;RFP RNF76	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5669	PlexinA3-Nrp1 complex	Mammalia	None	COS cells	O14786;P51805	8829;55558	MI:0007- anti tag coimmunoprecipitation	GO:0023052;GO:0010183;GO:0007399	signaling;pollen tube guidance;nervous system development	30.01;40.01.03.03;47.03.01	cellular signalling;guidance of longitudinal cell extension (e.g. pollen tube guidance, axonal pathfinding);nervous system	10520995	Neuropilin-1;Plexin-A3	NRP1;PLXNA3	NRP VEGF165R;PLXN4 SEX	None	Human is used as reference organism	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5759	PLXNA3-RANBPM complex	Human	None	HEK 293T cells	P51805;Q96S59	55558;10048	MI:0007- anti tag coimmunoprecipitation	GO:0000301;GO:0023052;GO:0010183	retrograde transport, vesicle recycling within Golgi;signaling;pollen tube guidance	20.09.07.07;30.01;40.01.03.03	retrograde transport;cellular signalling;guidance of longitudinal cell extension (e.g. pollen tube guidance, axonal pathfinding)	16672672	Plexin-A3 ;Ran-binding protein 9	PLXNA3;RANBP9	PLXN4 SEX;RANBPM	None	None	RanBPM has the potential to link Plexin-A receptors to retrograde transport and microtubule function in axonal guidance.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5811	p53-BCL2 complex	Mammalia	None	None	P04637;P10415	7157;596	MI:0019- coimmunoprecipitation	GO:0006915;GO:0005739	apoptotic process;mitochondrion	40.10.02;70.16	apoptosis (type I programmed cell death);mitochondrion	12667443	Cellular tumor antigen p53;Apoptosis regulator Bcl-2	TP53;BCL2	P53;None	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5812	p53-BCL2 complex	Mammalia	None	None	P04637;Q07817	7157;598	MI:0019- coimmunoprecipitation	GO:0006915;GO:0005739	apoptotic process;mitochondrion	40.10.02;70.16	apoptosis (type I programmed cell death);mitochondrion	12667443	Cellular tumor antigen p53;Bcl-2-like protein 1	TP53;BCL2L1	P53;BCL2L BCLX	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5922	RAF1-RAS complex, EGF induced	Human	None	None	P01112;P04049	3265;5894	MI:0006-anti bait coimmunoprecipitation	GO:0023052;GO:0005886	signaling;plasma membrane	30.01;70.02	cellular signalling;eukaryotic plasma membrane / membrane attached	16364920	GTPase HRas;RAF proto-oncogene serine/threonine-protein kinase	HRAS;RAF1	HRAS1;RAF	None	None	The authors showed that whereas EGF induces complex formation between RAS and C-RAF, and (G12V)RAS binds directly to C-RAF, a RAS:C-RAF complex is not induced by the impaired activity mutants of B-RAF or by (V600E)B-RAF.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5923	RAF1-BRAF complex, RAS stimulated	Human	None	Cos cells	P04049;P15056	5894;673	MI:0007- anti tag coimmunoprecipitation	GO:0023052	signaling	30.01	cellular signalling	16364920	RAF proto-oncogene serine/threonine-protein kinase;Serine/threonine-protein kinase B-raf	RAF1;BRAF	RAF;BRAF1, RAFB1	None	None	The authors found that C-RAF binds to B-RAF only under activating conditions, whereas mutant B-RAF binds to C-RAF constitutively. Additionally they showed that wild-type B-RAF can also activate C-RAF, but that C-RAF does not activate B-RAF.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5924	RAF1-CNK1 complex, RAS stimulated	Human	None	HEK 293T cells	P04049;Q969H4	5894;10256	MI:0007- anti tag coimmunoprecipitation	GO:0023052	signaling	30.01	cellular signalling	15845549	RAF proto-oncogene serine/threonine-protein kinase;Connector enhancer of kinase suppressor of ras 1	RAF1;CNKSR1	RAF;CNK1	None	None	The authors described that the interaction between the wild-type proteins of Raf and CNK was detectable but weak. Further they showed that coexpression of activated RasV12 enhanced the association between the two proteins, indicating that Raf-1 preactivated by RasV12 undergoes a conformational change that improves its binding to CNK1.	Homo sapiens (Human);Homo sapiens (Human)	2	2	537	0.30459444129325	6.56610800744879	0	Cal33-HSC6
5925	BRAF-CNK1 complex, not RAS stimulated	Human	None	HEK 293T cells	P15056;Q969H4	673;10256	MI:0007- anti tag coimmunoprecipitation	GO:0023052	signaling	30.01	cellular signalling	15845549	Serine/threonine-protein kinase B-raf;Connector enhancer of kinase suppressor of ras 1	BRAF;CNKSR1	BRAF1, RAFB1;CNK1	None	None	The authors showed that in contrast to Raf-1, B-Raf bound to CNK1 without the coexpression of activated Ras.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
5926	CNK1 homodimer complex	Human	None	HEK 293T cells	Q969H4	10256	MI:0007- anti tag coimmunoprecipitation	GO:0023052	signaling	30.01	cellular signalling	15845549	Connector enhancer of kinase suppressor of ras 1	CNKSR1	CNK1	None	None	The authors showed that coexpression of activators of the MAP kinase pathway such as RasV12 or the constitutively active MEK mutant MEK-Glu-217/Glu-221  strongly induced dimerization of the CNK proteins.	Homo sapiens (Human)	1	1	537	0.152297220646625	6.56610800744879	0	Cal33-HSC6
5928	CNK1-SRC-RAF1 complex	Human	None	HEK 293T cells	P04049;P12931;Q969H4	5894;6714;10256	MI:0007- anti tag coimmunoprecipitation	GO:0023052	signaling	30.01	cellular signalling	15845549	RAF proto-oncogene serine/threonine-protein kinase;Proto-oncogene tyrosine-protein kinase Src;Connector enhancer of kinase suppressor of ras 1	RAF1;SRC;CNKSR1	RAF;SRC1;CNK1	None	None	The results indicated that CNK1 regulates the Src-dependent activation of Raf-1 only under optimized conditions. Too low or too high amounts of CNK1 prevented the formation of the trimeric complex and promoted dimerization between CNK1 and Src or Raf-1, thereby preventing activation of Raf-1 by Src. The authors describe that CNK1 acts as a scaffold protein that assembles and coordinates two kinases of a single signaling pathway.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
6069	ESR1-GRIP1 complex	Human	None	U-937	P03372;Q9Y3R0	2099;23426	MI:0045- experimental	None	None	None	None	10611355	Estrogen receptor;Glutamate receptor-interacting protein 1	ESR1;GRIP1	ESR, NR3A1;None	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6092	c-Jun-ATF3 complex	Human	JUN-ATF3 complex	MDA-MB-231 cells	P05412;P18847	3725;467	MI:0019- coimmunoprecipitation	GO:0006355	regulation of transcription, DNA-templated	11.02.03.04	transcriptional control	27751807	Transcription factor AP-1 ;Cyclic AMP-dependent transcription factor ATF-3	JUN;ATF3	;	OMIM:114480 Breast cancer	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6143	KPNB1-RAN complex	Human	Importin beta-RanGTP complex	None	P62826;Q14974	5901;3837	MI:0051-fluorescence technologies;MI:0413-electrophoretic mobility shift assay	GO:0006913;GO:0006611;GO:0005634;GO:0005737;GO:0055085	nucleocytoplasmic transport;protein export from nucleus;nucleus;cytoplasm;transmembrane transport	70.10;70.03	nucleus;cytoplasm	9323134	GTP-binding nuclear protein Ran;Importin subunit beta-1	RAN;KPNB1	ARA24;NTF97	None	None	NLS proteins are transported into the nucleus by the importin alpha/beta heterodimer. Importin alpha binds the NLS, while importin beta mediates translocation through the nuclear pore complex. After translocation, RanGTP, whose predicted concentration is high in the nucleus and low in the cytoplasm, binds importin beta disassembling the importin alpha/beta heterodimer.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6185	SAPCD2-Galphai-LGN complex	Human	SAPCD2-GNAI1-GPSM2 complex	HEK-293T cells	P63096;P81274;Q86UD0	2770;29899;89958	MI:0019- coimmunoprecipitation;MI:0096- pull down	GO:0000132;GO:0008356	establishment of mitotic spindle orientation;asymmetric cell division	None	None	26766442	Guanine nucleotide-binding protein G;G-protein-signaling modulator 2 ;Suppressor APC domain-containing protein 2	GNAI1;GPSM2;SAPCD2	;LGN;C9orf140	None	None	None	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
6235	c-Fos-c-Jun-SAF-1 complex	Human	None	HTB-94 cells	P01100;P05412;P56270	2353;3725;4150	MI:0019- coimmunoprecipitation	GO:0006355;GO:0003677	regulation of transcription, DNA-templated;DNA binding	11.02.03.04;16.03.01	transcriptional control;DNA binding	19028685	Proto-oncogene c-Fos ;Transcription factor AP-1 ;Myc-associated zinc finger protein	FOS;JUN;MAZ	G0S7;;ZNF801	None	None	None	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
6270	DMTN-SYNE1- complex	Human	None	None	Q08495;Q8NF91	2039;23345	None	None	None	None	None	22927433	Dematin ;Nesprin-1	DMTN;SYNE1	DMT EPB49;C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6287	SLC2A1-DMTN-ADD2 complex	Human	None	human erythrocyte ghosts	P11166;P35612;Q08495	6513;119;2039	MI:0019- coimmunoprecipitation	GO:0003779;GO:0044425;GO:0030507	actin binding;membrane part;spectrin binding	None	None	18347014	Solute carrier family 2, facilitated glucose transporter member 1 ;Beta-adducin ;Dematin	SLC2A1;ADD2;DMTN	GLUT1;ADDB;DMT EPB49	None	None	The authors proposed model predicts a major role of GLUT1 interactions with dematin and adducin in stabilizing the vertical linkage of the junctional complex.	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
6296	SPATA2-CYLD complex	Human	None	U2OS cells	Q9NQC7;Q9UM82	1540;9825	MI:0071-molecular sieving	GO:0070536;GO:0045087;GO:0007249	protein K63-linked deubiquitination;innate immune response;I-kappaB kinase/NF-kappaB signaling	36.25.16.01;30.01.05.01.04	innate immune response (invertebrates and vertebrates);NIK-I-kappaB/NF-kappaB cascade	27591049	Ubiquitin carboxyl-terminal hydrolase CYLD;Spermatogenesis-associated protein 2	CYLD;SPATA2	CYLD1, KIAA0849;KIAA0757, PD1	None	None	The SPATA2 PUB domain (aa 1\u2013241) formes a 2:2 complex with dimeric CYLD USP domain of 136 kDa in SEC-MALS.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6300	CDKN1A-TP53-CDK1-PCNA complex	Human	None	None	P04637;P06493;P38936	7157;983;1026	MI:0045- experimental	None	None	None	None	7624128	Cellular tumor antigen p53;Cyclin-dependent kinase 1 ;Cyclin-dependent kinase inhibitor 1	TP53;CDK1;CDKN1A	P53;CDC2 CDC28A CDKN1 P34CDC2;CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1	None	None	None	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	3	2	537	0.456891661939875	4.37740533829919	0.0035157301094522	Cal33-HSC6
6332	Elongator complex (ELP1, ELP2, ELP3, ELP4, ELP5, ELP6)	Human	ELP1-ELP2-ELP3-ELP4-ELP5-ELP6 complex	HEK-293 cells	O95163;Q0PNE2;Q6IA86;Q8TE02;Q96EB1;Q9H9T3	8518;54859;55250;23587;26610;55140	MI:0019-coimmunoprecipitation	GO:0006357	regulation of transcription from RNA polymerase II promoter	None	None	22854966	Elongator complex protein 1 ;Elongator complex protein 6 ;Elongator complex protein 2 ;Elongator complex protein 5 ;Elongator complex protein 4 ;Elongator complex protein 3	IKBKAP;ELP6;ELP2;ELP5;ELP4;ELP3	ELP1 IKAP;ATP1 C3orf75 TMEM103;STATIP1;C17orf81 DERP6;C11orf19 PAXNEB;	OMIM:117100  Centrotemporal epilepsy (PMID:19172991).	None	None	Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human);Homo sapiens (Human)	6	2	537	0.91378332387975	2.1887026691496	0.0491155891794985	Cal33-HSC6
6428	SPG3A oligomer complex	Human	Atlastin-1 oligomer complex; ATL1 oligomer complex	None	Q8WXF7	51062	MI:0019-coimmunoprecipitation;MI:0397-two hybrid array;MI:0091-chromatography technologies;MI:0030-cross-linking studies	GO:0098796	membrane protein complex	None	None	14506257	Atlastin-1	ATL1	GBP3,SPG3A	None	None	Yeast two-hybrid analyses and co-immunoprecipitation studies demonstrated that atlastin-1 can self-associate, and gel-exclusion chromatography and chemical cross-linking studies indicated that atlastin-1 exists as an oligomer in vivo, most likely a tetramer. Membrane fractionation and protease protection assays revealed that atlastin-1 is an integral membrane protein with two predicted transmembrane domains; both the N-terminal GTP-binding and C-terminal domains are exposed to the cytoplasm. Together, these findings indicate that the SPG3A protein atlastin-1 is a multimeric integral membrane GTPase that may be involved in Golgi membrane dynamics or vesicle trafficking.	Homo sapiens (Human)	1	1	537	0.152297220646625	6.56610800744879	0	Cal33-HSC6
6430	ATL2-SPG31 complex	Human	REEP1-ATL2 complex	None	Q8NHH9;Q9H902	64225;65055	MI:0019-coimmunoprecipitation	GO:0007029;GO:0008017	endoplasmic reticulum organization;microtubule binding	42.07	endoplasmic reticulum	20200447	Atlastin-2;Receptor expression-enhancing protein 1	ATL2;REEP1	ARL6IP2;C2orf23,SPG31	Mutations in the receptor expression enhancing protein 1 (REEP1) gene have been reported to be associated with an autosomal dominant HSP phenotype (SPG31) (PMID:19034539). REEP proteins were required for ER network formation, and REEP1 also bound microtubules and promoted ER alignment along the microtubule cytoskeleton (PMID:20200447).	None	REEP1 coimmunoprecipitated with the human atlastin family members, atlastin-1, atlastin-2 and atlastin-3. ATL2 and ATL3 are highly similar to ATL1 in the membrane-spanning regions but divergent in the cytoplasmic C terminus.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6507	SERCA-PLN complex	Human	ATP2A2-PLN complex	HEK293 cells	P16615;P26678	488;5350	MI:0055-fluorescent resonance energy transfer	GO:0006816;GO:1901897;GO:0003697;GO:0035198	calcium ion transport;regulation of relaxation of cardiac muscle;single-stranded DNA binding;miRNA binding	None	None	26292938	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;Cardiac phospholamban	ATP2A2;PLN	ATP2B;PLB	OMIM:609909 Cardiomyopathy, dilated, 1P (PMID:25563649).	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6524	DZIP1-GLI3 complex	Human	None	HEK293 cells	P10071;Q86YF9	2737;22873	MI:0019-coimmunoprecipitation	GO:0060271;GO:0007224	cilium assembly;smoothened signaling pathway	30.05.02.16	hedgehog-dependent signalling pathway	23955340	Transcriptional activator GLI3;Zinc finger protein DZIP1	GLI3;DZIP1	None;DZIP, DZIP2, KIAA0996	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	2	537	0.30459444129325	6.56610800744879	0	Cal33-HSC6
6525	SPG3A-SPG33 complex	Human	ZFYVE27-Atlastin1 complex; SPG33-ATL1 complex	HEK293T cells	Q5T4F4;Q8WXF7	118813;51062	MI:0019-coimmunoprecipitation	GO:0005783;GO:0016192;GO:0071787;GO:0071788	endoplasmic reticulum;vesicle-mediated transport;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance	70.07;20.09.07	endoplasmic reticulum;vesicular transport (Golgi network, etc.)	24668814	Protrudin;Atlastin-1	ZFYVE27;ATL1	SPG33;GBP3,SPG3A	The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP.	None	Protrudin is an integral membrane protein that regulates polarized vesicular trafficking in neurons. It possesses a hairpin domain and interacts with HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, andreticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. Protrudin facilitates the interaction of Kif5 with Rab11, VAP family proteins, Surf4, and reticulon proteins, suggesting that it serves as an adaptor protein and that the protrudin-Kif5 complex contributes to the transport of these proteins in neurons.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6531	CEP164-DZIP1 complex	Human	None	HEK293 cells	Q86YF9;Q9UPV0	22873;22897	MI:0019-coimmunoprecipitation	GO:0042073;GO:0007224	intraciliary transport;smoothened signaling pathway	30.05.02.16	hedgehog-dependent signalling pathway	23955340	Zinc finger protein DZIP1;Centrosomal protein of 164 kDa	DZIP1;CEP164	DZIP, DZIP2, KIAA0996;KIAA1052, NPHP15	CEP164 is involved in Nephronophthisis 15 (PMID:22863007).	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6533	DZIP1-IFT88 complex	Human	None	HEK293 cells	Q13099;Q86YF9	8100;22873	MI:0019-coimmunoprecipitation	GO:0035720;GO:0060271;GO:0005814	intraciliary anterograde transport;cilium assembly;centriole	None	None	22863007	Intraflagellar transport protein 88 homolog;Zinc finger protein DZIP1	IFT88;DZIP1	TG737 TTC10;DZIP, DZIP2, KIAA0996	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6552	KIF5B-SPG33 complex	Human	ZFYVE27-KIF5B complex; Protrudin-KNS1 complex	HEK293T cells; HeLa cells	P33176;Q5T4F4	3799;118813	MI:0019-coimmunoprecipitation	GO:0005783;GO:0071787;GO:0071788;GO:0016192	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	70.07;20.09.07	endoplasmic reticulum;vesicular transport (Golgi network, etc.)	21976701	Kinesin-1 heavy chain;Protrudin	KIF5B;ZFYVE27	KNS, KNS1;SPG33	The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814).	None	Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6609	ATL2-SPG33 complex	Human	Protrudin-Atlastin2 complex; ZFYVE27-ARL6IP2 complex	HeLa cells; HEK293T cells	Q5T4F4;Q8NHH9	118813;64225	MI:0019-coimmunoprecipitation	GO:0005783;GO:0071787;GO:0071788;GO:0016192	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	70.07;20.09.07	endoplasmic reticulum;vesicular transport (Golgi network, etc.)	23969831	Protrudin;Atlastin-2	ZFYVE27;ATL2	SPG33;ARL6IP2	The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814).	None	Protrudin binds all three human atlastins (atlastin-1, atlastin-2, and atlastin-3) and endoplasmic reticulum-shaping proteins and regulates network formation. The interaction with atlastins required protrudin residues 1-205.	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6647	MED15-WWTR1 complex	Human	ARC105-TAZ complex	HEK293T cells	Q96RN5;Q9GZV5	51586;25937	MI:0019-coimmunoprecipitation	GO:0006351	transcription, DNA-templated	11	TRANSCRIPTION	18568018	Mediator of RNA polymerase II transcription subunit 15;WW domain-containing transcription regulator protein 1	MED15;WWTR1	ARC105 CTG7A PCQAP TIG1 TNRC7;TAZ	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6651	WWTR1-YAP1 complex	Human	TAZ-YAP complex	HEK 293T cells	P46937;Q9GZV5	10413;25937	MI:0019-coimmunoprecipitation	GO:0006351	transcription, DNA-templated	11	TRANSCRIPTION	16332960	Transcriptional coactivator YAP1;WW domain-containing transcription regulator protein 1	YAP1;WWTR1	YAP65;TAZ	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6652	WWTR1 homodimer	Human	TAZ homodimer	HEK 293T cells	Q9GZV5	25937	MI:0019-coimmunoprecipitation	GO:0006351	transcription, DNA-templated	11	TRANSCRIPTION	16332960	WW domain-containing transcription regulator protein 1	WWTR1	TAZ	None	None	None	Homo sapiens (Human)	1	1	537	0.152297220646625	6.56610800744879	0	Cal33-HSC6
6660	LATS1-NPHP4 complex	Human	None	HEK293T cells	O75161;O95835	261734;9113	MI:0019-coimmunoprecipitation	GO:0035329	hippo signaling	None	None	21555462	Nephrocystin-4;Serine/threonine-protein kinase LATS1	NPHP4;LATS1	KIAA0673;WARTS	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6661	NEK8-WWTR1 complex	Human	NPHP9-TAZ complex	HEK293T cells	Q86SG6;Q9GZV5	284086;25937	MI:0019-coimmunoprecipitation	GO:0005634;GO:0035329	nucleus;hippo signaling	70.1	nucleus	23026745	Serine/threonine-protein kinase Nek8;WW domain-containing transcription regulator protein 1	NEK8;WWTR1	JCK, NEK12A, NPHP9;TAZ	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6676	WWTR1-YWHAQ complex	Human	TAZ-14-3-3 complex	HEK293T cells	P27348;Q9GZV5	10971;25937	MI:0019-coimmunoprecipitation	GO:0035329;GO:0006351	hippo signaling;transcription, DNA-templated	11	TRANSCRIPTION	21555462	14-3-3 protein theta;WW domain-containing transcription regulator protein 1	YWHAQ;WWTR1	None;TAZ	None	The authors did not mention which 14-3-3 protein was used.	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6706	CAPN1-HSP90AB1 complex	Human	None	human leukemic T cell JA3 cells	P07384;P08238	823;3326	MI:0019-coimmunoprecipitation	GO:0006508	proteolysis	None	None	25575026	Calpain-1 catalytic subunit;Heat shock protein HSP 90-beta	CAPN1;HSP90AB1	CANPL1;HSP90B HSPC2 HSPCB	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6726	GRASP1-GRIP1 complex	Human	None	HEK293 cells	Q4V328;Q9Y3R0	56850;23426	MI:0019-coimmunoprecipitation	GO:0005088	Ras guanyl-nucleotide exchange factor activity	None	None	10896157	GRIP1-associated protein 1;Glutamate receptor-interacting protein 1	GRIPAP1;GRIP1	KIAA1167;None	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
6732	RHINO-TopBP1 complex	Human	None	HEK293 Flp-In T-REx cells; transfected Sf21 cells	Q92547;Q9BSD3	11073;83695	MI:0007-anti tag coimmunoprecipitation	GO:0006281;GO:0000077;GO:0000785;GO:0005634	DNA repair;DNA damage checkpoint;chromatin;nucleus	10.01.05.01;70.10	DNA repair;nucleus	25602520	DNA topoisomerase 2-binding protein 1;RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	TOPBP1;RHNO1	KIAA0259;C12orf32,RHINO,HKMT1188	None	None	None	Homo sapiens (Human);Homo sapiens (Human)	2	1	537	0.30459444129325	3.28305400372439	0.023157818515345	Cal33-HSC6
